1. Home
  2. |Experience
  3. |Trump First Year: Business Impact

Trump First Year: Business Impact

Overview

What to Expect from the New Administration and the 119th Congress

In a business environment characterized by tremendous change and impact as a the result of the new Trump Administration and  119th Congress. Crowell is focused on providing clients with timely and actionable insights that can help to inform forward-looking business priorities and strategies. We will continue to update and expand the list of focus areas and the impact insights included within each area.

To view our Executive Order Updates and Analysis, click here.

Please sign up to receive alerts, webinar invitations, breaking news analyses, and forward-looking insights.

Insights

Client Alert | 3 min read | 05.23.25

Executive Order Seeks Most-Favored-Nation Drug Pricing and HHS Announces Price Targets

On May 12, 2025, President Trump issued an Executive Order titled "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients," which aims to reduce the costs of prescription drugs and biologics for American consumers and other payers. This Order revives a plan from President Trump’s first term and follows his April Executive Order, “Lowering Drug Prices by Once Again Putting Americans First,” which also sought to reduce drug prices. With drug prices in the United States nearly three times higher than many other countries, this second Order asks drug manufacturers to adopt Most-Favored-Nation (MFN) pricing for drugs sold in the United States or face potential regulation. MFN pricing would tether drug prices offered in the United States to the lower-cost prices offered in other comparably developed nations, such as Canada, Germany, or the United Kingdom....